Double-blind randomized placebo-controlled clinical trial of omega 3 fatty acids for the treatment of diabetic patients with nonalcoholic steatohepatitis
S Dasarathy, J Dasarathy, A Khiyami… - Journal of clinical …, 2015 - journals.lww.com
Background: Nonalcoholic steatohepatitis (NASH) is common and severe in patients with
diabetes mellitus. Although, there are no effective treatments for NASH in diabetic patients,
preliminary reports suggest that polyunsaturated fatty acids (PUFA) may be beneficial in
these patients. Aim: A prospective, randomized, double-blind placebo-controlled study (NCT
00323414) was performed in NASH patients with diabetes. Clinicaltrials. gov (NCT
00323414). Subjects and Methods: A total of 37 patients (50.6±9.8 y) with well-controlled …
diabetes mellitus. Although, there are no effective treatments for NASH in diabetic patients,
preliminary reports suggest that polyunsaturated fatty acids (PUFA) may be beneficial in
these patients. Aim: A prospective, randomized, double-blind placebo-controlled study (NCT
00323414) was performed in NASH patients with diabetes. Clinicaltrials. gov (NCT
00323414). Subjects and Methods: A total of 37 patients (50.6±9.8 y) with well-controlled …